ABSTRACT In response to replication stress, a phospho-signaling cascade is activated and required for coordination of DNA repair and replication of damaged templates (intra-S-phase checkpoint) . How phospho-signaling coordinates the DNA replication stress response is largely unknown. We employed state-of-the-art liquid chromatography tandem-mass spectrometry (LC-MS/MS) approaches to generate high-coverage and quantitative proteomic and phospho-proteomic profiles during replication stress in yeast, induced by continuous exposure to the DNA alkylating agent methyl methanesulfonate (MMS) . We identified 32,057 unique peptides representing the products of 4296 genes and 22,061 unique phosphopeptides representing the products of 3183 genes. A total of 542 phosphopeptides (mapping to 339 genes) demonstrated an abundance change of greater than or equal to twofold in response to MMS. The screen enabled detection of nearly all of the proteins known to be involved in the DNA damage response, as well as many novel MMS-induced phosphorylations. We assessed the functional importance of a subset of key phosphosites by engineering a panel of phosphosite mutants in which an amino acid substitution prevents phosphorylation. In total, we successfully mutated 15 MMSresponsive phosphorylation sites in seven representative genes including APN1 (base excision repair); CTF4 and TOF1 (checkpoint and sister-chromatid cohesion); MPH1 (resolution of homologous recombination intermediates); RAD50 and XRS2 (MRX complex); and RAD18 (PRR). All of these phosphorylation site mutants exhibited MMS sensitivity, indicating an important role in protecting cells from DNA damage. In particular, we identified MMS-induced phosphorylation sites on Xrs2 that are required for MMS resistance in the absence of the MRX activator, Sae2, and that affect telomere maintenance.
C ELLS utilize excision repair and DNA damage tolerance pathways without significant delay of the cell cycle to address low levels of DNA base damage (Hishida et al. 2009; Huang et al. 2013) , while more extensive damage is hallmarked by the activation of additional checkpoints, prolonged cell cycle arrest, and utilization of additional repair mechanisms (Lazzaro et al. 2009) . A classic example of an agent that elicits a profoundly different DNA damage response (DDR) at high and low doses is the monofunctional alkylating agent methyl methanesulfonate (MMS) (Friedberg and Friedberg 2006; Hanawalt 2015) . At low doses, the MMS lesions are well tolerated by wild-type cells and do not elicit any discernible sensitivity ; however, at higher concentrations, MMS-induced DNA damage present during the S phase leads to prolonged replication fork stall, a phenomenon termed "replication stress" (Shimada et al. 2002; Zeman and Cimprich 2013) . As a result of replication stress, cells synchronize into a lengthened S phase due to a kinase-mediated checkpoint response (Paulovich and Hartwell 1995; MurakamiSekimata et al. 2010) .
Much of the known signaling in the DDR is mediated by a group of highly conserved checkpoint kinases (e.g., ATR/ Mec1, ATM/Tel1, Chk2/Rad53, Chk1), which activate an extensive phospho-signaling network to enhance DNA repair capacity as well as induce cell cycle delay at G1, intra-S, or G2/M to allow additional time for cells to deal with higher doses of DNA damage (Weinert and Hartwell 1988; Siede et al. 1993; Paulovich and Hartwell 1995) . In Saccharomyces cerevisiae, the intra-S-phase checkpoint is mediated by the serine/threonine protein kinases Mec1 and Tel1 (Paulovich and Hartwell 1995; Zeman and Cimprich 2013) . Mec1 plays the predominant role in the activation of the intra-S-phase checkpoint, whereas Tel1 plays a backup role (Weinert et al. 1994; Greenwell et al. 1995) . The long stretches of singlestranded DNA (ssDNA) exposed during replication fork stalling after DNA damage contribute to the activation of Mec1 and induction of the intra-S-phase checkpoint (Tercero et al. 2003; MacDougall et al. 2007) .
Activation of the Mec1 kinase leads to activation of two wellknown, bifurcated pathways: the Rad9-mediated DNA-damage checkpoint (DDC) pathway, and the Mrc1/Tof1/Ctf4/Csm3-mediated S phase-specific DNA-replication checkpoint (DRC) (Alcasabas et al. 2001; Katou et al. 2003; Uzunova et al. 2014) . Similar to the Mec1/Tel1 relationship, the Rad9-mediated DDC pathway is required for MMS resistance, whereas the Mrc1-mediated DRC plays a backup role in MMS resistance (Foss 2001) . Phosphorylations of Rad9 and Mrc1 in turn facilitate phosphorylation of the downstream checkpoint kinases (Rad53 and Chk1) (Vialard et al. 1998; Sanchez et al. 1999; Alcasabas et al. 2001) , which, in turn, phosphorylate additional substrates, including Pds1 and Cdc5 polo-kinase, both of which contribute to cell cycle delay (Sanchez et al. 1999) . Rad53 also phosphorylates and activates another kinase, Dun1, which contributes to the hyper-phosphorylation and inactivation of the transcriptional repressor Crt1 and leads to increased expression of genes related to DNA repair, including RNR (ribonucleotidediphosphate reductase) genes (Huang et al. 1998) .
Many downstream DNA repair proteins are reported to be phosphorylated during checkpoint activation, including proteins involved in post-replication repair (PRR), homologous recombination (HR), DNA replication, DNA repair, histone modification, and chromatin remodeling (Smolka et al. 2007; Chen et al. 2010; Bastos de Oliveira et al. 2015) . For example, phosphorylation of Rev1 by Mec1 increases the proficiency of Polz-mediated translesion synthesis (Pages et al. 2009 ), which together with the template-switch subpathways of PRR are important in dealing with replication stress, because the lesion-containing ssDNA resulting from a replication fork stall would not be subject to excision repair (Yang et al. 2010; Allen et al. 2011 ) and must be circumnavigated using PRR pathways. Much of the core PRR machinery is known to be phosphorylated, including Rad6, Rad18, Rev1, Mms2, and Rad5 (Chi et al. 2007; Albuquerque et al. 2008; Holt et al. 2009; Helbig et al. 2010 ), yet the physiological importance of most of these phosphorylations is unknown.
Over 100 checkpoint-induced phosphorylations have been identified in previous studies (Smolka et al. 2007; Chen et al. 2010; Bastos de Oliveira et al. 2015) . However, because previous studies used a relatively high concentration (0.05%) of MMS, in which cells accumulate in the G1 phase and do not replicate the bulk of the genome (Murakami-Sekimata et al. 2010) , phospho-signaling events that are exclusive to intra-Sphase checkpoint activation may be missing in these data sets. The identification and interpretation of these phospho-signaling events is of significance, as the key regulatory steps by which cells sense and respond to replication stress are poorly mapped out.
We utilized recent advances in proteomic technologies that enable near-comprehensive coverage of the yeast proteome to identify phosphorylation events during continuous treatment with a sublethal dose of MMS, which induces a replication stress response (Paulovich and Hartwell 1995; Zeman and Cimprich 2013) . We identified many novel phosphorylation sites. We assessed the functional importance of a subset of key phosphosites by screening mutants in which an amino acid substitution prevents phosphorylation. All of these phosphorylation site mutants exhibited MMS sensitivity, indicating an important role for phosphorylation at these sites in protecting cells from DNA damage. Moreover, we performed a series of genetic and functional characterizations of phosphosite mutants, and we found that MMS-induced phosphorylation sites on Xrs2 are required for MMS resistance in the absence of the MRX activator, Sae2, and affect telomere maintenance.
Materials and Methods
Public access to the liquid chromatography tandemmass spectrometry data All mass spectrometry data have been deposited to the ProteomeXchange Consortium (http://proteomecentral. proteomexchange.org) via the PRIDE partner repository (Vizcaíno et al. 2013) with the data-set identifier PXD002344 (reviewer account details: username: reviewer63953@ebi.ac. uk; password: s7u3qKaX).
Strains, medium, and growth conditions S. cerevisiae strains used in this study are listed in Table 1 . Strain BY4741 was obtained from Open Biosystems. All of the other strains used in this study are derived from BY4741. YPD medium contains 1% yeast extract, 2% peptone, and 2% glucose. SILAC (Stable Isotope Labeling by Amino acids in Cell culture) medium is synthetic defined (SD)-Lys-Arg (2% glucose) liquid medium supplemented with 40 mg/liter of lysine (light or heavy) and 20 mg/liter of arginine (light or heavy). Heavy lysine is L-lysine:2HCl (U-13 C6, 99%; U-15 N2, 99%); heavy arginine is L-arginine:HCl (U-13 C6, 99%; U-15 N4, 99%). All light and heavy lysine and arginine were purchased from Cambridge Isotope Laboratories Inc. MMS was purchased from Acros Organics (AC254609). YPD plates containing MMS were prepared 15 hr prior to use.
Quantitative MS screen for MMSresponsive phosphopeptides
Metabolic labeling of proteins, extraction, and digestion: Wild-type cells were metabolically labeled for .20 generations in SILAC medium. The heavy (H)-SILAC-labeled cells were then continuously exposed to 0.01% MMS to induce replication stress, and the light (L)-SILAC-labeled cells were mock-exposed. After 3 hr, heavy and light cells were harvested and lysed using a previously described trichloroacetic acid (TCA) lysis method (Ziv et al. 2011) . To ensure reproducibility, the entire experiment was repeated, and the labels were swapped such that the (L)-SILAC-labeled wild-type yeast cells were exposed to 0.01% MMS for 3 hr, and the (H)-SILAC-labeled wild-type yeast cells were mock-exposed. The protein pellets from TCA prep were resuspended in urea buffer [300 mM Tris, pH 8.0, 6 M Urea (Sigma U0631)].
Lysates from heavy and light cells were mixed 1:1 by protein mass. Five milligrams of each protein lysate was reduced in 100 mM Tris/20 mM TCEP (Thermo 77720) for 30 min at 37°w ith shaking, followed by alkylation with 50 mM iodoacetamide (Sigma I1149) in the dark at room temperature. Lysates were then diluted 1:10 with 100 mM Tris, pH 8, and trypsin was added at a 1:50 trypsin:protein ratio (by mass). After 2 hr, a second trypsin aliquot was added at a 1:100 trypsin: protein ratio. Digestion was carried out overnight at 37°with shaking. After 16 hr, the reaction was quenched with formic acid (FA) (Acros Organics 14793-2500) with a final concentration 1% by volume. Digests were desalted using HydrophilicLipophilic-Balanced (HLB) cartridges (Waters WAT094225) with vacuum. HLB cartridges were washed with 3 vol of 0.1% FA in 80% acetonitrile (ACN) (Fisher A955-4) and then equilibrated with four washes of 0.1% FA. The digests were applied to the cartridge and then washed with 4 vol 0.1% FA before being eluted drop by drop with three washes of 0.1% FA in 80% ACN. The eluate was then aliquotted by volume, and digests were lyophilized and stored at 280°until use.
Fractionation of proteome and phosphoproteome samples:
The desalted tryptic digest was fractionated by high-pH reverse phase (RP) liquid chromatography, as follows: five milligrams of the protein digest were loaded onto an LC system consisting of an Agilent 1200 HPLC (Agilent, Santa Clara, CA) with mobile phases of 5 mM ammonium bicarbonate (NH 4 HCO 3 ), pH 10 (A) and 5 mM NH 4 HCO 3 in 90% ACN, pH 10 (B). The peptides were separated by a 10-3 250-mm XBridge C18 5-mm column (Waters catalog #186003256) over 50 min at a flow rate of 2.5 ml/min by the following time table: hold 5% B for 1 min, gradient from 5 to 40% B for 35 min, gradient from 40 to 60% B for 5 min, gradient from 60 to 90% B for 4 min, gradient from 90 to 5% B for 1 min, and re-equilibrate at 5% B for 4 min. Fractions were collected at 0.5-min intervals from 2 to 50 min by the shortest path by row in a 2-ml-deep well plate (Thermo 95040450). The high pH reverse phase fractions were concatenated into 12 samples by column (e.g., sample 1 contained fractions from wells A1, B1, C1, D1, etc.). For proteome analysis, 2% of each concatenated fraction was dried down (lyophilization) and re-suspended in 0.1% FA in 3% ACN for liquid chromatography tandem-mass spectrometry (LC-MS/MS) analysis. The remaining 98% was processed to enrich for phosphopeptides using immobilized metal affinity chromatography as previously described (Ficarro et al. 2009 ). Briefly, Ni-NTA-agarose beads (catalog #36113, Qiagen, Valencia, CA) were stripped with EDTA and incubated in a 10-mM FeCl 3 solution to prepare magnetic Fe 3+ -NTA-agarose beads. Samples were reconstituted in 400 ml of 0.1% TFA in 80% ACN and incubated for 30 min with 75 ml of the 5% bead suspension, with mixing at 1400 3 g at room temperature. After incubation, the beads were washed three times each with 150 ml of 0.1% TFA in 80% ACN and then once with 150 ml of 0.1% TFA. Phosphorylated peptides were eluted from the beads twice using 150 ml of 500 mM potassium phosphate, pH 7, after incubating for 3 min each time. Samples were desalted using StageTips loaded with reverse-phase material (Rappsilber et al. 2007) , dried down, and resuspended in 0.1% FA and 3% ACN for LC-MS/MS analysis.
Mass-spectrometry-based analysis: Global and phosphopeptide-enriched samples were analyzed by LC-MS/MS on a Thermo LTQ-Orbitrap Velos mass spectrometer. Peptides were loaded onto an LC system consisting of a nanoAcquity HPLC (Waters, Milford, MA) with mobile phases of 0.1% FA in water (A) and 0.1% FA in ACN (B). The peptides were separated on a 75-mm 3 250-mm C18, 130 Å, 1.7-mm column (Waters catalog #186003545) over 152 min at a flow rate of 300 nl/min, with a gradient from 3 to 40% B for 120 min, a gradient from 40 to 90% B for 2 min, a hold of 90% B for 10 min, and reequilibration at 3% B for 20 min. The HPLC was coupled to an LTQ-Orbitrap Velos hybrid mass spectrometer using an Advance CaptiveSpray source (Michrom Bioresources, Auburn, CA) operated in positive ion mode. A spray voltage of 1700 V was applied to the nanospray tip (catalog #559/25000/20). MS/MS analysis consisted of one full-scan MS from 300 to 2000 m/z at resolution 30,000, followed by 15 data-dependent MS/MS scans. Dynamic exclusion parameters included repeat count 1, exclusion list size 500, and exclusion duration 15 sec.
Analysis of LC-MS/MS data
Raw MS/MS spectra were searched against version 3.69 of the Yeast International Protein Index sequence database using three independent search engines (MaxQuant/Andromeda, Spectrum Mill, and xTandem) (Craig and Beavis 2004; Kapp et al. 2005; Cox and Mann 2008) . All searches were performed with the tryptic enzyme constraint set for up to two missed cleavages, oxidized methionine set as a variable modification, and carbamidomethylated cysteine set as a static modification. For MaxQuant, the peptide MH+ mass tolerances were set at 20 ppm. For X!Tandem, the peptide MH+ mass tolerances were set at 62.0 Da with post-search filtering of the precursor mass to 50 ppm, and the fragment MH+ mass tolerances were set at 60.5 Da. For Spectrum Mill, peptide MH+ mass tolerances were set at 20 ppm and fragment MH+ mass tolerances were set at 60.7 Da. The overall false discovery rate (FDR) was set at #0.03 based on a decoy database search. SILAC ratios and phosphosite localization probabilities are reported only in the MaxQuant results. Any site with a probability .0.8 was considered to be localized; ambiguous sites with a lower probability were manually examined to verify the location of the phosphorylation and ensure the quality of the reported results. For manual examination, the MS/MS spectra were examined to identify ions with the loss of phosphate, which is characteristic of Ser/Thr-phosphorylated peptides, and to confirm that all of the major ions were properly assigned and the assignment of the phosphate group to the specific site was correct. Quantification of the heavy:light ratios was performed using MaxQuant software, with a minimum ratio count of 2 and using unique + razor peptides for quantification. Functional enrichment analysis was conducted using the software package Funspec (Robinson et al. 2002) .
Gene disruptions and integrations
All gene disruptions and integrations were achieved by homologous recombination at their respective chromosomal loci by standard PCR-based methods (Longtine et al. 1998) . Briefly, a deletion cassette with a 0.5-kb region flanking the target open reading frame (ORF) was amplified by PCR from the corresponding xxxD::KANMX strain of the deletion array (Open Biosystems) and transformed into the target strain for gene knockout. The primers used in the gene disruptions were designed using 20-bp sequences that are 0.5 kb upstream and downstream of the target gene (Reid et al. 2002) .
For gene disruptions utilizing the LEU2MX or HIS3MX cassette, the xxxD::KANMX strain from the deletion array was converted to xxxD::LEU2MX or xxxD::HIS3MX. The cassette conversion was achieved by amplifying the LEU2MX or HIS3MX cassette with primers MX-F (59-ACATGGAGGCCCA GAATACCCT-39) and MX-R (59-CAGTATAGCGACCAGCATT CAC-39) from plasmids pFA6a-Leu2MX6-GAL1 and pFA6a-His3MX6-pGAL1, respectively (Longtine et al. 1998) , and the resulting PCR product was used to transform the xxxD:: KANMX strain (the 2MX cassettes each carry an identical 59 Translational elongation factor EF-1 (TEF) promoter and 39 terminator, which facilitates the KANMX::LEU2MX or KANMX::HIS3MX conversion).
To integrate the Myc-tag into the C terminus of the XRS2 gene, a region of plasmid pFA6a-13Myc-KanMX6 was amplified by PCR using primers that contain 55 bp of XRS2 gene sequence (55 nucleotides before and after the stop codon), followed by 20 bp homologous to plasmid pFA6a-13Myc-KanMX6 (F2 and R1) (Longtine et al. 1998) . The PCR product was used to transform the indicated target yeast strains and integrated Myc-tag in the C terminus of the endogenous XRS2 with KanMX marker. The primers used were 59-GGCGACGAC GACGATGACGACGGTCCGAAGTTTACGTTCAAAAGAAGAAA AGGACGGATCCCCGGGTTAATTAA-39 (XRS2-13myc F2) and 59-ATGATAATGCAAAATATAATTTAATGAAATTGGAAA TACTCGGAAAATTTATCAGAATTCGAGCTCGTTTAAAC-39 (XRS2-13myc R1).
In vivo site-directed mutagenesis
We followed a protocol modified from a previously published yeast mutagenesis method (Storici et al. 2001 ) based on transformations of oligonucleotides that allow the rapid creation of site-directed DNA mutations in vivo. The protocol includes two steps: The first step involves the integration of a counterselectable reporter URA3 cassette into the target gene at the position of the codon where the change is desired, resulting in replacement of the three-nucleotide codon with URA3. (The URA3 cassette with a 50-bp region flanking the three-nucleotide codon was amplified by PCR from pRS406 and transformed into the target strain). The second step involves transformation with the mutation-containing oligonucleotides that eliminate the URA3 cassette. The two 93-bp "integrative recombinant oligonucleotides" are complementary to each other and contain the three-nucleotide mutated codon flanked by 45-bp sequences upstream and downstream of the URA3 cassette. Cells were transformed with these two complementary oligonucleotides, and loss of the URA3 cassette was counterselected using 5-fluoroorotic acid (TRC, F595000). The removal of URA3 and reinstatement of the continuous coding sequence was further confirmed by PCR. The acquired mutation was confirmed by sequencing of the entire gene. By repeating these processes, multiple mutations were made in a single gene.
Colony-based survival assays
Three independent, sequence-confirmed transformants were analyzed for each phospho-mutant, along with wild-type and deletion mutant controls. Log-phase cells were sonicated and counted using a Beckman Coulter Z1 particle counter. Cells were serially diluted in PBS and plated onto YPD plates 6 appropriate concentrations of MMS. Viability was determined by scoring the number of colony-forming units (CFU) after 3-4 days at 30°. Viability was calculated as the number of CFUs on a MMS plate/the number of CFUs on an YPD plate.
Western blotting
Cell extracts were prepared from log-phase cells using a TCA lysis method (Ziv et al. 2011) . Eighty micrograms of total protein were loaded on SDS-PAGE. Myc-tagged Xrs2 wildtype and mutant proteins were detected with anti-MYC-HRP (Fisher MA121316HRP). Rad53p was detected with the yC-19 anti-Rad53 antibody (Santa Cruz).
Southern blotting
Southern blotting for telomere lengths was carried out using a previously described DNA probe targeting telomeric Y9 regions (Singer et al. 1998) . Digoxigenin (DIG)-labeled probe synthesis was carried out by PCR using the Roche DIG Probe Synthesis Kit following the manufacturer's instructions. Genomic DNA was prepared using a Yeastar genomic DNA kit (Zymo Research D2002). Genomic DNA preparations were digested overnight with XhoI (NEB R0146S) and separated on 1% agarose gels. Separated DNA molecules were transferred onto nylon membranes via blot sandwich overnight in 203 SSC buffer (3.0 M NaCl and 0.3 M sodium citrate, at pH 7.0). DNA molecules were cross-linked onto the membrane using a UV cross-linker (Fisher Scientific) at 60 mJ/cm 2 , and the membrane was incubated with the Y9 telomeric DIGlabeled probe overnight. Antibody detection of the DIG probe was performed using a DIG luminescent detection kit (Roche 11363514910), and blots were imaged on a ChemiDoc XRS system (Bio-Rad).
Data availability
The authors state that all data necessary for confirming the conclusions presented in the article are represented fully within the article.
Results

LC-MS/MS-based analysis of proteomic and phosphoproteomic responses associated with MMS-induced replication stress
To more comprehensively characterize the signaling events that comprise the replication stress response, we performed large-scale quantitative proteomic and phosphoproteomic profiling of yeast cells 6 continuous exposure to 0.01% MMS. To do this, we metabolically labeled wild-type yeast cells in heavy SILAC medium (with Arg and Lys labeled with 13 C and 15 N) (Mann 2014) and exposed the cells to 0.01% MMS for 3 hr. Lysate from these cells was mixed 1:1 by protein mass with lysate from untreated yeast cells grown in light SILAC medium. The protein lysates were digested with trypsin, and the resulting peptides were subjected to fractionation via offline reverse-phase HPLC and split into aliquots for global proteome and phosphoproteome analyses. Phosphopeptides were enriched via iron metal affinity chromatography (Ficarro et al. 2009) , and both the global and phosphopeptide-enriched samples were analyzed by LC-MS/MS ( Figure 1A ). Both data sets were analyzed using three search engines (MaxQuant/Andromeda, Spectrum Mill, and X!Tandem), and results for this combined analysis were reported for an FDR # 0.03 (see Materials and Methods).
In the global proteome, we identified 32,056 unique peptides representing the products of 4296 genes (Supplemental Material, Table S1A), and in the phosphoproteome we identified 22,061 unique phosphopeptides representing the products of 3183 genes ( Figure 1B and Table S1B ). To ensure reproducibility, the entire experiment was repeated with the SILAC labels swapped (reverse experiment), with cells exposed to MMS cultured in light SILAC medium and the untreated cells cultured in heavy SILAC medium. The results for the reverse experiment were comparable to the initial forward experiments; we identified 39,480 unique peptides representing 4594 gene products in the global proteome (Table S1C), and 21,547 unique phosphopeptides representing 3183 gene products in the phosphoproteome ( Figure 1B and Table S1D ). Importantly, in our current study, we detected virtually all of the proteins known to be involved in the replication stress response ( Figure S1 ). The coverage achieved for the yeast proteome was not significantly biased toward high-abundance proteins, as shown by comparing our LC-MS/MS results to the immunodetection-based global analysis of tagged protein expression in yeast from Ghaemmaghami et al. (2003) (Figure 1C) .
We assessed for changes in protein abundance and phosphorylation after MMS treatment using the SILAC ratios. To minimize the noise present in the reported ratios (by focusing on only the most robust MS signals), peak areas (both heavy and light) in the lowest 20% of the results from the phospho and global proteome were removed from the analysis ( Figure S2 ). To assess protein abundance changes, we considered proteins with at least two peptides quantified in both the forward and reverse experiments with reported ratios within 50%. Of the 1476 proteins that qualify based on our filtering criteria (Table S2) , we found that 66 proteins exhibited a change in abundance of $2s (or 1.5-fold) based on the median of all peptide ratios of a protein ( Figure S3 ). Of the 66 MMS-responsive proteins, 56 were up-regulated and 10 were down-regulated after MMS treatment ( Figure 1B and Table S3 ). The 56 MMS-induced proteins were highly biased for particular Gene Ontology (GO) biological processes such as oxidation-reduction processes (P , 10 214 ), deoxynucleotide biosynthesis (P = 1.3 3 10 210 ), and metabolic processes (P = 9.74 3 10 29 ) ( Figure S4 ). These are consistent with previous reports that the expression of ribonucleotidediphosphate reductase complex subunits (RNR genes) was stimulated by DNA damage checkpoint pathways (Gasch et al. 2001) and that exposure of cells to MMS triggers an oxidative stress response (Mizumoto et al. 1993; Gasch et al. 2001; Salmon et al. 2004) .
For the analysis of the phosphoproteome, of the 6644 phosphopeptides quantified in the overlap of both the forward and reverse experiments (Table S4) , 5524 phosphosites could be confidently localized to a specific residue (localization probability score .0.8) (Table S5) , and 4449 of these sites were previously reported in the S. cerevisiae phosphorylation site database (PhosphoGRID) as well as in recently published results (Amoutzias et al. 2012; Sadowski et al. 2013; Bastos de Oliveira et al. 2015) ; as such, the remaining 1075 are novel site-of-phosphorylation identifications.
Based on the relative quantification measured by SILAC ratios, we identified 549 phosphopeptides mapping to 346 proteins that exhibited a change in abundance of $2s (or twofold) in both forward and reverse experiments ( Figure 1B and Table S6 ). Of these, 471 peptides contained a single phosphorylated residue, 77 were doubly phosphorylated, and 1 was triply phosphorylated. A total of 360 modifications were on serine residues, 51 on threonine, and 1 on tyrosine. With regards to directionality of the change in response to MMS, 401 phosphopeptides (420 phosphorylation sites in 264 proteins) increased in abundance after MMS treatment, indicating MMS-induced phosphorylation, while 148 decreased in abundance ( Figure 1B and Table S6 ). In addition, the 264 genes showing MMS-induced phosphorylation were highly biased for genes with particular GO biological processes: DNA-dependent transcription (P = 1.1 3 10 213 ), DNA repair (P = 2.5 310 212 ), DNA replication (P = 4.1 3 10 212 ), DNA damage response (P = 9.2 3 10 211 ), cell cycle (P = 3.4 3 10 210 ), and mitosis (P = 4.1 3 10 29 ) ( Figure 1D ).
Among the 420 MMS-inducible phosphorylation sites, 376 were confident sites (with localization probability score .0.8) (Table S7 ). Of these, 271 sites were previously reported (Amoutzias et al. 2012; Sadowski et al. 2013; Bastos de Oliveira et al. 2015) , and 105 were novel sites. Not surprisingly, 71/271 (26%) were previously annotated as "DNA damage induced," and 34/271 (12%) were "cell cycle regulated." However, the majority of previously identified phosphosites 164/271 (61%) had not been previously attributed to any biological condition (Table S7 ), suggesting that phosphoproteomic DNA damage signaling has to date been largely unmapped.
We next looked for motif enrichment among the 376 MMSinducible phosphosites identified in our study. We found that 84/376 (22%) of the MMS-inducible phosphosites exhibited a consensus sequence for Mec1/Tel1 (S/T-Q), as compared to 188/5524 or 3% of all confident phosphorylation sites identified (P = 6.2 3 10 258 ). Therefore, Mec1/Tel1 (S/T-Q) consensus sequence is significantly enriched. Although other kinase motifs were represented among the MMS-induced phosphosites, none showed significant enrichment, such as an S/T-C Rad53 motif (P = 0.495), an S/T-P minimal Cdk1 consensus sequence (P = 0.075), and an S/T-D/E minimal Casein kinase 2 consensus sequence (P = 0.366).
Selection of biologically important phosphorylation sites for further functional analysis
Our large-scale phosphoproteomic analyses yielded a significant number of novel MMS-dependent phosphorylation events. However, differential phosphoproteomics alone does not provide functional information regarding the importance of any specific phosphosite for surviving DNA damage. Thus we next chose a subset of previously uncharacterized MMSinduced phosphosites for further characterization via study of the effects of site-directed mutagenesis of the phosphosite of interest to nonphosphorylatable alanine. We chose evolutionally and functionally conserved DDR genes and avoided multiply phosphorylated proteins (due to the technical challenge of generating 3+ point mutations via site-directed mutagenesis). In total, we successfully mutated 15 MMSinducible phosphorylation sites in seven representative genes including the following: APN1 (Base excision repair); CTF4 To ensure reproducibility, the entire experiment was repeated, and the labels were swapped such that the (L)-SILAC-labeled wild-type yeast cells were exposed to 0.01% MMS for 3 hr, and the (H)-SILAC-labeled wildtype yeast cells were mock-exposed. *bRP: basic reverse-phase (bRP) liquid chromatography (LC). (B) Global and phospho-proteome coverage. Note that "MMS-responsive" phospho-peptides include the peptides the phosphorylation of which increases (SILAC ratio $2) or decreases (SILAC ratio #0.5) after MMS treatment. (C) The high coverage of the yeast proteome achieved by LC-MS/MS is not biased. Bar graph is extracted from Ghaemmaghami et al. (2003) and represents the abundance distribution of 80% of the yeast proteome based on immuno-detection. Lines represent the abundance-based coverage achieved in our LC-MS/MSbased global and phospho scans. (D) The genes encoding MMS-inducible phosphoproteins are enriched in the functional categories of cell cycle regulation and DDR. Gene ontology enrichment analysis was conducted on the 264 MMS-induced phosphoproteins ($2s or twofold) using the Funspec software package (http://funspec.med.utoronto.ca/). After inputting the 264 gene names and setting the P-value cutoff as 10 26 , the following processes were found to be enriched: DNA-dependent transcription (P = 1.1 3 10 213 ), DNA repair (P = 2.5 3 10 212 ), DNA replication (P = 4.1 3 10 212 ), DNA damage response (P = 9.2 3 10 211 ), cell cycle (P = 3.4 3 10 210 ), and mitosis (P = 4.1 3 10 29 ).
and TOF1 (checkpoint and sister-chromatid cohesion); MPH1 (resolution of HR intermediates); RAD50 and XRS2 (MRX complex); and RAD18 (PRR) ( Table 2 and see also Figure  S5 for MS1 quantification and MS/MS identification of Xrs2 and Tof1 peptides).
The vast majority of phosphorylation sites tend to locate in structurally disordered loop regions, and mutations in loop regions tend not to disrupt protein function (Iakoucheva et al. 2004; Gsponer et al. 2008) . Eleven of the selected 15 phosphosites were predicted with high confidence to locate in loop regions (Phyre 2 program, http://www.sbg.bio.ic.ac.uk/ phyre2/), including apn1 S350 , ctf4 T401 , ctf4 T411 , mph1 T540 , mph1 S542 , rad18 T155 , rad18 T282 , tof1 S379 , tof1 S626 , xrs2 S349 , and xrs2 T675 . All of the nonphosphorylatable mutants demonstrate normal doubling time in rich medium, in contrast to many of their respective congenic deletion mutants ( Figure  2A ), suggesting that the mutant proteins are functional under normal growth conditions. We next assessed the functional importance of these mutated phospho-targets by examining the nonphosphorylatable amino acid substitution alleles for dose-dependent MMS sensitivity. We determined that all mutants conferred mild but significant MMS sensitivities in response to 0.01 and 0.03% MMS, which were intermediate between the sensitivity of the wild-type strain and a full deletion of the ORF ( Figure  2B ). From these data we conclude that each of the phosphosites contributes to its respective protein's role in surviving MMS-mediated DNA damage; however, based on the intermediate phenotypes observed, none is the sole determinant of its protein's respective role in the DNA damage response. tof1 S379A, S626A and xrs2 S349A, T675A showed enhanced phenotypes in specific genetic backgrounds
The DDR collectively encompasses a wide array of both competing and collaborating repair and signaling mechanisms, with many proteins contributing multiple, sometimes-independent functions to more than one such pathway. As such, we hypothesized that the intermediate DDR phenotype conferred by each phospho-mutant may reflect the disabling of a subset of each respective protein's complete repertoire of DDR functions. This hypothesis predicts that the nonphosphorylatable mutant alleles may show interactions with only a subset of the genes with which the corresponding deletion allele interacts. We tested this prediction by examining known interactions of tof1D and xrs2D in the respective nonphosphorylatable allele backgrounds, as described below.
Tof1 has been implicated in sister-chromatid cohesion as well as in the activation of the DRC at stalled forks (Katou et al. 2003; Xu et al. 2004 ). These two known functions of Tof1 are independent of each other (Xu et al. 2004) . Specifically, tof1D srs2D and tof1D ctf8D display synthetic lethality, which could result from sister-chromatid cohesion defects of tof1D (Xu et al. 2004) . TOF1 also has a negative genetic interaction with the checkpoint mediator RAD9 (Foss 2001; Pan et al. 2006) , as well as a positive interaction (suppression) with the checkpoint recovery mediator DIA2 (Fong et al. 2013) (Table 3 and Figure S6 ). When these interactions were tested in a nonphosphorylatable tof1 background, we found that tof1 S379A, S626A rad9D cells displayed enhanced sensitivity as compared to either congenic single mutant. In addition, a tof1 S379A, S626A dia2D strain exhibited less MMS sensitivity (suppression) than a dia2D single mutant ( Figure S6 ). The phospho-mutant tof1 S379A, S626A rad9D displayed intermediate MMS sensitivity vs. the tof1D rad9D double-deletion strain, indicating at least a partial role in survival in the absence of a fully functional checkpoint ( Figure 3A) , while tof1 S379A, S626A dia2D fully recapitulated the suppression of loss of DIA2 as seen in tof1D ( Figure 3A) . While the exact biochemical nature of the suppression of MMS sensitivity by tof1D in a checkpoint-recovery-defective background is unknown, it has been hypothesized that loss of the Tof1-mediated replication checkpoint helps resumption of growth in dia2D cells Since PRR genes play an essential role in the replication stress response, RAD18 was included even though the induction of phosphorylation by MMS for these proteins was detected in only one of the forward or label-swap experiments. The same is true for the phosphorylation of Mph1 T540 and Apn1 S356 . The mass spectra of the detected phosphopeptides from these gene products (in either the forward or label-swap experiment) were manually inspected and confirmed. a The observed phenotypes reflect phenotypes of the phospho-mutants in which all detected MMS-inducible phosphosites are mutated. b The mass spectra were not able to distinguish between phosphorylation of Mph1 on S542 vs. S543 or phosphorylation of Rad18 on T282 vs. S284; in all ambiguous cases, both sites were mutated.
in the presence of DNA damage (Fong et al. 2013) , and these data suggest that tof1 S379A, S626A may thus be defective in replication checkpoint activation. In contrast, the intermediate sensitivity phenotype exhibited by tof1 S379A, S626A rad9D shows that the role of these two phosphosites in survival in a checkpoint-defective background is not absolute and suggests that additional biochemical properties not regulated by phosphorylation at these residues are still functional. While Tof1 is hypothesized to play multiple roles at stalled replication forks, Xrs2 has been implicated in even more varied DDR functions including checkpoint signaling (Nakada et al. 2003 (Nakada et al. , 2004 , recombination (Cejka 2015) , and telomere maintenance (Nugent et al. 1998 ). As such, we chose 10 genes (known to interact with xrs2D and comprising a wide variety of DDR functions) to test the interaction of Xrs2 phospho-mutants with the loss of these functions. The genes chosen were SGS1, EXO1, RTT109, YKU80, CLB2, POL32, RAD27, APN1, CTF4, and SRS2. These genes are involved in many different cellular processes such as HR, nonhomologous end jointing (NHEJ), telomere maintenance, DNA replication, DNA repair, sister-chromatid cohesion, and cell cycle. Deletion of each of these 10 genes was tested for interaction effects with xrs2 S349A, T675A (Table 3 and Figure S7) . Of the 10 deletion mutants, two (exo1D and yku80D) exhibited interaction effects with xrs2 S349A, T675A ( Figure S7 ). xrs2 S349A, T675A exo1D cells displayed enhanced MMS sensitivity as compared to exo1D (at 0.02% MMS) ( Figure 3B ). Consistent with previously reported results (Nakada et al. 2004) , complete deletion of the XRS2 ORF in combination with exo1D renders cells sensitive to MMS at very low concentrations (0.002%) ( Figure 3B ). At such dose, in contrast to the extreme MMS sensitivity of xrs2D exo1D, the xrs2 S349A, T675A exo1D interaction is nonevident, and the sensitivity of this strain is identical to exo1D. We conclude that phosphorylation of Xrs2 at Ser349 and Thr675 is important for Xrs2's role in the DDR, and the nonexistent phenotype at low doses of MMS shows that some DDR functionality is retained.
In contrast to xrs2 S349A, T675A exo1D, we observed that the xrs2 S349A, T675A yku80D double mutant displayed no enhanced sensitivity to MMS vs. yku80D alone ( Figure S7 ). Log-phase cultures were diluted in YPD such that all cultures started at a density of 5 3 10 5 cells/ml. The cell density of each culture was subsequently measured every 2 hr for 10 hr. The log numbers were then plotted. The doubling times were calculated from determining the slope of the straight line of each graph after linear regression. Three independent, sequence-verified isolates of each genotype were assayed, and the error bars represent the standard deviation for the three isolates. (B) Cell survival in two doses of MMS. For quantitative survival analyses in MMS, log-phase wildtype, nonphosphorylatable point mutants and deletion mutants were serially diluted in PBS and spread onto YPD, YPD + 0.01% MMS, or YPD + 0.03% MMS plates. Viable cells were determined by the number of CFUs after 3 days at 30°. Three independent sequence-verified, independent transformants of each strain were tested, and the error bars represent the standard deviation for the three isolates. Of note, a rad18D strain is highly sensitive to MMS so that zero CFUs were obtained from a 0.03% MMS plate.
However, while xrs2 S349A, T675A did not exhibit a growth defect on its own, xrs2 S349A, T675A yku80D cells grew at a slower rate than yku80D alone (note that the full ORF deletion xrs2D exhibits a growth phenotype, in contrast to the phosphomutant) ( Figure 3C ). From these data, we conclude that phosphorylation of Xrs2 on Ser-349 and/or Thr-675 is required for normal growth in an yku80D background, discussed further below.
Mutations of Ser349 and Thr675 of Xrs2 affect telomere maintenance and entry into senescence
As described above, we observed that the phospho-mutant xrs2 S349A, T675A exhibits a growth defect when combined with the end-capping mutant yku80D. One hypothesis for this genetic interaction is that xrs2 S349A, T675A yku80D could have an enhanced telomere defect, as loss of both genes was previously reported to result in synergistic telomere and growth defects (Nugent et al. 1998 ) (see also Figure 3C ). Consistent with this hypothesis, all xrs2 phospho-mutants (xrs2 S349A , xrs2 T675A , and xrs2 S349A, T675A ) also showed mild (but significant) shortening of telomeres relative to wild type ( Figure  4A ), and there was no decrease in xrs2 S349A, T675A expression (e.g., due to misfolding and degradation) as compared to the wild-type Xrs2p ( Figure 4C ). Furthermore, consistent with the genetic interaction between xrs2 S349A, T675A and yku80D, the xrs2 S349A, T675A yku80D double mutants showed additive effects and exhibited telomere lengths shorter than yku80D ( Figure 4B ). In addition, the phospho-mutants xrs2 S349A yku80D and xrs2 T675A yku80D also displayed shorter telomere length than the yku80D single mutant ( Figure 4B ). From these data, we conclude that phosphorylations of S349 and T675 on Xrs2 are important for telomere maintenance independent of Yku80, supporting the hypothesis that the slow-growth phenotypes likely result from defective telomere maintenance.
In telomerase-deficient cells, telomeres shorten over each round of DNA replication, leading to replicative senescence ("est" phenotype) (Gilson and Geli 2007; Palm and de Lange 2008) , a phenotype that is accelerated by deletion of XRS2 (Chang et al. 2011 ). As such, we hypothesized that loss of phosphorylation of S349 and/or T675 on Xrs2 would also cause an accelerated senescence phenotype in the absence of telomerase. To test this, we generated a knockout of EST3 (an essential subunit of telomerase) in the xrs2 phosphomutant backgrounds and examined the kinetics of entry into senescence. For this purpose, freshly made est3D mutants were serially spotted onto YPD plates for testing of survival (passage 1). After 2 days at 30°, cells from the grown patches were scraped and serially spotted on a fresh YPD plate (passage 2). The same process was repeated after another 2 days at 30°(passage 3). Initially, cell viability (passage 1) was equal among wild-type and est3D single and double mutants ( Figure 4D ). As expected, the est3D mutants entered senescence at passage 3, whereas wild-type cells remained viable ( Figure 4D ). However, when est3D was combined with nonphosphorylatable alleles of XRS2, entry into senescence was accelerated, as evidenced by a reduction in viability in passage 2 ( Figure 4D ). From these data we conclude that phosphorylation of S349 and T675 on Xrs2 prevents early entry into senescence in the absence of telomerase, with the failure to maintain normal-length telomeres (as described above) one likely cause.
Mutation of Xrs2 phosphorylation sites results in severe MMS sensitivity in the absence of the MRX activator Sae2
The Mre11 complex plays a parallel role with Exonuclease 1 (Exo1) in producing long-range ssDNA tails (Bernstein et al. 2013; Cannavo and Cejka 2014) . The genetic interaction of xrs2 S349A, T675A with exo1D raises the possibility that The genetic interactions with tof1 S379A, S626A and xrs2 S349A, T675A were selected from the manually curated genetic interactions with tof1D and xrs2D in the Saccharomyces Genome Database (http://www.yeastgenome.org/). b xrs2 S349A, T675A yku80D showed enhanced growth defects (but not MMS sensitivity) as compared to yku80D. xrs2 S349A, T675A may confer a defect in resection at sites of DNA damage. Since one of the functions of Xrs2 is to activate Mre11 nuclease activity , we hypothesized that the phenotype of xrs2 S349A, T675A may be enhanced by deletion of another activator of Mre11 nuclease, Sae2 (Cannavo and Cejka 2014) . Indeed, we observed that the xrs2 S349A, T675A sae2D double-mutant strain was much more sensitive to MMS than the single mutants ( Figure 3B and Figure 5A ). To determine if only one of the two phosphorylation sites is responsible for the genetic interaction with sae2D, we further tested the MMS sensitivity of xrs2 S349A sae2D and xrs2 T675A sae2D ( Figure 5A ). We found that the xrs2 T675A sae2D strain displayed strong sensitivity to MMS as compared to sae2D. In contrast, an xrs2 S349A sae2D strain showed mild (if any) MMS sensitivity ( Figure 5A) . Thus, the phosphorylation sites differentially contribute to the MMS sensitivity in the absence of SAE2.
The Mre11 endonuclease activity (promoted by Sae2) is known to be required for removing the MRX complex from DSB ends to facilitate subsequent long-range resection (Clerici et al. 2006; Bernstein et al. 2013; Chen et al. 2015) . Retention of MRX on the damage site results in prolonged checkpoint activation and growth defects (Clerici et al. 2006; Chen et al. 2015) . One hypothesis to explain the strong interaction between xrs2 S349A, T675A and sae2D is that xrs2 S349A, T675A may also be defective in activating the endonuclease activity of Mre11 (without disruption of MRX); thus mutation of Ser349 and Thr675 on Xrs2 coupled with loss of Sae2 may cause drastic inactivation of Mre11 endonuclease activity, leading to retention of MRX and uncontrolled checkpoint activation. If this is the case, removing one of the checkpoint kinases Mec1 or Tel1 may alleviate the severe MMSsensitivity phenotype at low concentrations of MMS when checkpoint functions are not critical for survival . To test this prediction, we deleted MEC1 or TEL1 in the xrs2 S349A, T675A sae2D background. We found that both mec1D and tel1D suppressed the MMS-sensitivity phenotype of xrs2 S349A, T675A sae2D ( Figure 5B ). Furthermore, although MMS-treated xrs2 S349A, T675A cells exhibited only a modest increase in Rad53 phosphorylation in various genetic backgrounds tested ( Figure S8 ), we found that when xrs2 S349A, T675A was combined with deletion of the 9-1-1 checkpoint factors RAD17 or RAD24, xrs2 S349A, T675A was able to suppress the MMS sensitivity of the 9-1-1 mutants ( Figure 5C ). Since the 9-1-1 complex and Tel1/Xrs2 act in parallel to activate the checkpoint ), these observations suggest that the increased checkpoint activity in xrs2 S349A, T675A may compensate for the loss of checkpoint activity caused by deletion of 9-1-1 genes. From these data, we conclude that the phosphorylation of residues Ser349 and Thr675 on XRS2 contributes to attenuation of MMS-triggered checkpoints.
Discussion
Among a panel of proteins in which we mutated S/T/Y sites identified in our screen to alanine, disruption of these sites Figure 3 tof1 S379A, S626A and xrs2 S349A, T675A recapitulate a subset of the genetic interactions manifested by their respective deletion mutants. (A) tof1 S379A, S626A shows negative interaction with rad9D and positive interaction with dia2D in the presence of MMS. The survival rates of wildtype and mutant strains in 0.01% MMS were determined as in Figure 2B . Three independent, PCR-confirmed gene knockout transformants of each strain were tested, and the error bars represent the standard deviation for the three isolates. [The tof1D rad9D strain is sml1D tof1D rad9D. The sml1D single mutation does not affect growth or survival at the tested MMS concentrations (data not shown)]. (B) xrs2 S349A, T675A shows genetic interactions with sae2D and exo1D in the presence of MMS. The assay of survival rates of wild-type, single-, and double-mutant strains in indicated MMS concentrations were performed as in Figure 2B . Three independent, PCR-confirmed gene knockout transformants of each strain were tested, and the error bars represent the standard deviation for the three isolates. (C) xrs2 S349A, T675A shows a synergistic growth interaction with yku80D. The wild type, xrs2 S349A, T675A , and yku80D single-and double-mutant cells were grown in YPD to log phase at 30°. The cultures were diluted such that every culture started at a density of 10 6 cells/ml. The cell density of each culture was subsequently measured every 2 hr for 10 hr. The doubling time of each strain was calculated as in Figure 2A . Three independent, PCR-confirmed gene knockout transformants of each strain were tested, and the error bars represent the standard deviation for the three isolates.
resulted in DNA damage sensitivity and recapitulated known genetic interactions that have been previously observed via deletion of the entire ORF. Of note, in many cases the DDR phenotypes observed due to amino acid substitution were intermediate to that of the full ORF deletion; this could be due to a number of scenarios: (1) many DDR proteins are hyperphosphorylated, and removal of one to two sites may only partially abrogate the DDR phenotype; (2) some DDR proteins likely play multiple functional roles in the DDR, of which only a subset may be dependent on phosphorylation; or (3) one or more substitutions may destabilize the local or overall protein structure, potentially resulting in a null or hypomorphic allele. The majority of phosphorylation sites that we tested were predicted to be in structurally disordered loop regions, and none confers a growth defect when mutated; therefore, they are unlikely to disrupt protein structure (Iakoucheva et al. 2004; Gsponer et al. 2008; Dephoure et al. 2013) . Nevertheless, we cannot entirely rule out this possibility. A common approach is to generate phospho-mimicking (aspartic or glutamic acid) amino acid substitutions of the site of interest and to determine if the observed phenotypes are reversed or neutralized. However, since the chemical environment introduced by phosphorylation is not completely equivalent to that of negatively charged residues, the failure rate of such studies is high, and the behavior of phosphomimetic mutations can be hard to interpret (Hunter 2012; Dephoure et al. 2013) . In our studies, none of the phospho-mutants showed growth defects under normal conditions (in contrast to the full ORF deletion mutants, which exhibited mild-tosignificant growth defects) (Figure 2A) , suggesting that the engineered phosphosite substitutions behave similarly to wild type. Moreover, the expression level of Myc-tagged xrs2 S349A, T675A is indistinguishable from wild-type Xrs2 ( Figure 4B ), suggesting that the mutant protein is not targeted for degradation.
Previous studies have demonstrated that members of the MRX complex are regulated by phosphorylation in response to DNA damage (Usui et al. 2001; Simoneau et al. 2014; SorianoCarot et al. 2014) . Our phospho-proteomic studies raise the possibility of novel phosphorylation mechanisms that act on Xrs2. The novel phosphosite Thr675 of Xrs2 plays a major role in cell survival in MMS when Sae2 is absent ( Figure 5 ). SAE2 is required for activating Mre11 endonuclease activity (Cannavo and Cejka 2014) . Given the strong genetic interaction with sae2D, we hypothesized that Thr675 on Xrs2 may function in a parallel pathway of activating Mre11 endonuclease activity, which is essential for timely removal of the MRX complex from DSB ends, and the retention of MRX results in prolonged checkpoint activation and growth defects (Clerici et al. 2006; Bernstein et al. 2013; Chen et al. 2015) . Our genetic studies showed that tel1D and mec1D checkpoint mutants suppressed the severe sensitivity of an xrs2 S349A, T675A sae2D strain to MMS ( Figure 5B) , consistent with the idea that prolonged checkpoint activation is responsible for the severe MMS-sensitivity phenotype. Furthermore, xrs2 S349A, T675A by itself suppressed the MMS sensitivity of the 9-1-1 checkpoint mutants ( Figure 5C ). Figure 4 xrs2 S349A and xrs2 T675A mutants affect telomere maintenance and entry into senescence. (A and B) xrs2 S349A and xrs2 T675A strains exhibit a shortened telomere phenotype. XhoI-digested DNA was analyzed by Southern blot using a probe complementary to the Y9 subtelomere. (C) xrs2 phospho-mutant protein levels are unchanged as compared to the wild-type protein. Cells harboring Myc-tagged Xrs2 (wild-type or phospho-mutants) were grown in YPD to log phase and then harvested and lysed. The cell extracts were subjected to immunoblotting with anti-Myc antibodies. (D) Senescence assay on wild-type and xrs2 phosphomutants. Initially, wild-type and freshly made est3D cells were resuspended in PBS to equal concentrations (10 7 cells/ml) and serial 10-fold dilutions were spotted on YPD plates. After 2 days at 30°, cells were scraped from the grown patches and resuspended in PBS to equal concentrations (10 7 cells/ml). Serial 10-fold dilutions were spotted on fresh YPD plates as above. To confirm the results, the entire process was repeated, and consistent results were obtained.
These phenotypes are consistent with the possibility that these phosphosites may promote MRX removal, possibly through activation of Mre11 in parallel with Sae2, and affect checkpoint reversal.
Alignment of Xrs2 with its human ortholog Nbs1 indicates that the phosphosite Thr675 occurs in a highly conserved C-terminal region and adjacent to an important ATM phosphorylated site Ser615 (http://www.ebi.ac.uk/Tools/psa/ emboss_needle/). The C-terminal region contains highly conserved and functionally critical motifs, which are responsible for interaction with Mre11 and Tel1/ATM (Demuth and Digweed 2007; Schiller et al. 2012) . In addition, the most common mutation responsible for Nijmegen breakage syndrome, 657D5, also locates in the C-terminal of Nbs1 (Demuth and Digweed 2007) . It will be of interest to investigate whether mutation of Ser615 on Nbs1 exhibits a genetic interaction with the Sae2 ortholog CtIP.
The MRX complex also plays important roles in telomere maintenance. Cells lacking any one component of MRX (mrxD) have short and stable telomeres (Wellinger and Zakian 2015) . In addition, mrxD also shows an accelerated senescence phenotype in the absence of telomerase (Chang et al. 2011) . These phenotypes, albeit milder, are also reflected in both xrs2 phosphosite mutations, suggesting that phosphorylation on these residues may play important roles in telomere maintenance. Many genes involved in the DNA damage checkpoint response also affect telomere length (Wellinger and Zakian 2015) . Tel1 is the master kinase that regulates telomere maintenance, and the kinase activity of Tel1 is required for such roles (Greenwell et al. 1995; Morrow et al. 1995) . It was previously reported that Tel1 phosphorylates several proteins at telomeres including Xrs2 (Mallory et al. 2003; Tseng et al. 2006; Sridhar et al. 2014) . However, it is unclear whether phosphorylation of Xrs2 by Tel1 is important for telomere maintenance (Mallory et al. 2003) . In addition, the consensus sequences around the two MMSinduced phosphosites in this study do not contain S/T-Q, and therefore it is unlikely that Tel1 directly phosphorylates these sites. Another kinase that plays important roles in telomere maintenance is the cell cycle master regulator Cdc28 (Enserink and Kolodner 2010) . Telomeres are actively maintained during late S phase, which is attributed mainly to the function of Cdk to promote telomere maintenance (Enserink and Kolodner 2010) . Cdc28 has been recently implicated to be responsible for the phosphorylation of Ser349, studied here, on Xrs2 (Holt et al. 2009; Simoneau et al. 2014) . It was found that mutation of this site and six other S/T-P sites on Xrs2 specifically stimulates NHEJ (Simoneau et al. 2014) . Recent Figure 5 xrs phospho-mutants show genetic interactions with sae2D and rescue MMS-sensitive phenotype caused by 9-1-1 mutants. (A) xrs phospho-mutant cells show severe sensitivity to MMS when combined with sae2D. The strains were grown in YPD overnight at 30°. Serial 10-fold dilutions were spotted onto YPD and YPD + MMS plates. The plates were incubated in 30°for 2 days. (B) mec1D and tel1D suppressed the severe sensitivity of xrs2 S349A, T675A sae2D to MMS. The spot assay followed the same protocol as in A. (C) xrs2 S349A, T675A suppressed the MMS sensitivity of 9-1-1 mutants. The cell survival rates of wildtype and mutant strains in the presence of MMS were determined as in Figure 2B . Three independent, PCR-confirmed gene knockout transformants of each genotype were assayed, and the error bars represent the standard deviations for the three isolates.
studies have shown that Nbs1 is also phosphorylated by Cdk1/2 to promote DSB repair in human cells (Wohlbold et al. 2012) . The phosphorylation on Nbs1 occurs at Ser432, which is not far away from Ser349 on Xrs2, based on protein/ protein alignments (http://www.ebi.ac.uk/Tools/psa/ emboss_needle/). How the phosphorylation of Ser349 by Cdc28 affects telomere maintenance and NHEJ or whether there is a crosstalk between these two functions has yet to be investigated.
A wide variety of human diseases, including cancer, have been found to be associated with deregulated phosphorylation events and, in particular, mutated kinases (Cohen 2002 ). Thus, a careful reconstruction of the vast phospho-signaling networks that tightly regulate the DNA damage response, including the identification of all key points of failure for which a defect in phosphorylation has catastrophic consequences, will aid the development of novel anticancer therapies. and setting the p-value cut-off as 10 -6 , the following processes were found to be enriched: oxidation and reduction (p < 10 -14 ), deoxynucleotide biosynthesis (p = 1.3 X 10 -10 ), metabolism (p = 9.7 X 10 -10 ). Figure 2A . Three independent, PCR-confirmed gene knockout transformants of each genotype were assayed, and the error bars represent the standard deviation for the three isolates. B) xrs2 S349A, T675A exo1 showed enhanced MMS-sensitivity as compared to exo1.
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The log-phase wild type and mutant cells were serially diluted in PBS and spread onto YPD, YPD + MMS plates. Viable cells were determined as in Figure 2B . Three independent, PCR-confirmed gene knockout transformants of each strain were tested, and the error bars represent the standard deviation for the three isolates. The xrs2 S349A, T675A xxx strains that show significant genetic interactions were indicated with curly brackets and subjected to further assays shown in Figure   3B . 
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